{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:59:28Z","timestamp":1781067568183,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ30896"],"award-info":[{"award-number":["2022JJ30896"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117556","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T15:51:54Z","timestamp":1763653914000},"page":"117556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["MMP28 promotes tumorigenesis and gemcitabine resistance in pancreatic cancer by promoting glycolysis through interaction with SND1"],"prefix":"10.1016","volume":"243","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6446-2982","authenticated-orcid":false,"given":"Juan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2025.117556_b0005","first-page":"318","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2025.117556_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117633","article-title":"Circular RNAs in pancreatic cancer progression","volume":"552","author":"Bao","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.bcp.2025.117556_b0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/CM9.0000000000002758","article-title":"Pancreatic ductal adenocarcinoma chemoresistance: from metabolism reprogramming to novel treatment","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.bcp.2025.117556_b0020","doi-asserted-by":"crossref","first-page":"C540","DOI":"10.1152\/ajpcell.00331.2022","article-title":"Barriers and opportunities for gemcitabine in pancreatic cancer therapy","volume":"324","author":"Beutel","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117556_b0025","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.7150\/thno.23259","article-title":"Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-\u03baB signaling pathway","volume":"8","author":"Yu","year":"2018","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.bcp.2025.117556_b0030","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1158\/1078-0432.CCR-19-3975","article-title":"Integrative genomic analysis of gemcitabine resistance in pancreatic cancer by patient-derived xenograft models","volume":"27","author":"Yang","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.bcp.2025.117556_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28145567","article-title":"Matrix metalloproteinases inhibitors in cancer treatment: an updated review (2013-2023)","volume":"28","author":"Almutairi","year":"2023","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bcp.2025.117556_b0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1600-0625.2008.00782.x","article-title":"Epilysin (MMP-28)\u2013structure, expression and potential functions","volume":"17","author":"Illman","year":"2008","journal-title":"Exp. Dermatol."},{"issue":"1809","key":"10.1016\/j.bcp.2025.117556_b0045","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2019.0559","article-title":"Dynamic expression of MMP28 during cranial morphogenesis","volume":"375","author":"Gouignard","year":"2020","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117556_b0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7150\/ijbs.31335","article-title":"Upregulated MMP28 in hepatocellular carcinoma promotes metastasis via notch3 signaling and predicts unfavorable prognosis","volume":"15","author":"Zhou","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2025.117556_b0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2407-11-200","article-title":"MMP28 (epilysin) as a novel promoter of invasion and metastasis in gastric cancer","volume":"11","author":"Jian","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2025.117556_b0060","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.2147\/OTT.S309576","article-title":"High matrix metalloproteinase 28 expression is associated with poor prognosis in pancreatic adenocarcinoma","volume":"14","author":"Liu","year":"2021","journal-title":"Onco Targets Ther"},{"issue":"12","key":"10.1016\/j.bcp.2025.117556_b0065","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025320","article-title":"High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"10.1016\/j.bcp.2025.117556_b0070","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1074\/jbc.M111.321646","article-title":"Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor \u03baB and miR-221","volume":"287","author":"Santhekadur","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0075","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1038\/s41467-023-43245-8","article-title":"SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer","volume":"14","author":"Liao","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0080","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8453","article-title":"Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis","volume":"49","author":"Zhao","year":"2023","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13058-023-01731-3","article-title":"The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation","volume":"25","author":"Zhang","year":"2023","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/modpathol.2017.106","article-title":"A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms","volume":"31","author":"Wang","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bcp.2025.117556_b0095","article-title":"Retrospective case series analysis of RAF family alterations in pancreatic cancer: real-world outcomes from targeted and standard therapies","volume":"5","author":"Hendifar","year":"2021","journal-title":"JCO Precis. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117556_b0100","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/2159-8290.CD-14-0617","article-title":"Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes","volume":"4","author":"Chmielecki","year":"2014","journal-title":"Cancer Discov."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2025.117556_b0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcancer.2022.09.001","article-title":"Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers","volume":"86","author":"Comandatore","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2025.117556_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.phrs.2018.03.015","article-title":"p53 and glucose metabolism: an orchestra to be directed in cancer therapy","volume":"131","author":"Gomes","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13046-020-01765-x","article-title":"Glycometabolic rearrangements\u2013aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications","volume":"39","author":"Cao","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117556_b0120","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/tox.24014","article-title":"SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A-mediated SLC7A11 expression and promoting aerobic glycolysis","volume":"39","author":"Li","year":"2024","journal-title":"Environ. Toxicol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117556_b0125","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.bcp.2025.117556_b0130","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","article-title":"LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1\u03b1 pathway","volume":"81","author":"Xu","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13046-019-1055-9","article-title":"Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression","volume":"38","author":"Shi","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2025.117556_b0140","article-title":"TGF-\u03b21 facilitates TAp63\u03b1 protein lysosomal degradation to promote pancreatic cancer cell migration","volume":"10","author":"Gao","year":"2021","journal-title":"Biology (basel)"},{"key":"10.1016\/j.bcp.2025.117556_b0145","article-title":"Hypoxia-related gene FUT11 promotes pancreatic cancer progression by maintaining the stability of PDK1","volume":"11","author":"Cao","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-020-01237-y","article-title":"LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40170-024-00354-2","article-title":"PAF1\/HIF1\u03b1 axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer","volume":"12","author":"Ogunleye","year":"2024","journal-title":"Cancer Metab."},{"issue":"19","key":"10.1016\/j.bcp.2025.117556_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194940","article-title":"LINC01526 promotes proliferation and metastasis of gastric cancer by interacting with TARBP2 to induce GNG7 mRNA decay","volume":"14","author":"Zhou","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bcp.2025.117556_b0165","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.62347\/GGVE9638","article-title":"ITGA5 promotes cervical cancer progression by regulating IMP3 recruitment of HK2 mRNA","volume":"17","author":"Zhou","year":"2025","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117556_b0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"issue":"10","key":"10.1016\/j.bcp.2025.117556_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101751","article-title":"Cheminformatics and biomolecular dynamics studies towards the discovery of anti-staphylococcal nuclease domain-containing 1 (SND1) inhibitors to treat metastatic breast cancer","volume":"31","author":"Makki Almansour","year":"2023","journal-title":"Saudi Pharm J"},{"issue":"21","key":"10.1016\/j.bcp.2025.117556_b0180","doi-asserted-by":"crossref","first-page":"e3072","DOI":"10.21769\/BioProtoc.3072","article-title":"mRNA stability assay using transcription inhibition by Actinomycin D in mouse pluripotent stem cells","volume":"8","author":"Ratnadiwakara","year":"2018","journal-title":"Bio Protoc"},{"issue":"4","key":"10.1016\/j.bcp.2025.117556_b0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00262-024-03632-6","article-title":"Clinical immunotherapy in pancreatic cancer","volume":"73","author":"Ye","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2025.117556_b0190","article-title":"Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: environmental factors, molecular profile and drug\/nanotherapeutic approaches","volume":"240","author":"Ashrafizadeh","year":"2024","journal-title":"Environ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12885-019-5768-0","article-title":"A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic\/prognostic potential","volume":"19","author":"Gobin","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2025.117556_b0200","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820974017","article-title":"Expression and clinical significance of MMP-28 in Bladder Cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13020-021-00534-y","article-title":"A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation","volume":"16","author":"Wu","year":"2021","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0210","doi-asserted-by":"crossref","first-page":"17211","DOI":"10.1038\/s41598-023-44506-8","article-title":"Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer","volume":"13","author":"Luan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117556_b0215","first-page":"1","article-title":"Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives","author":"Toledo","year":"2024","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117556_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1226639","article-title":"Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer","volume":"11","author":"Wei","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.117556_b0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpb.2023.09.014","article-title":"Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer","volume":"192","author":"Silli","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.bcp.2025.117556_b0230","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1158\/1078-0432.CCR-12-2986","article-title":"Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer","volume":"19","author":"Yu","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.117556_b0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MED.0b013e328357f0cb","article-title":"Fructose consumption and cancer: is there a connection?","volume":"19","author":"Port","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"9","key":"10.1016\/j.bcp.2025.117556_b0240","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00424-020-02448-4","article-title":"SGLT2 and cancer","volume":"472","author":"Wright","year":"2020","journal-title":"Pflugers Arch."},{"issue":"2","key":"10.1016\/j.bcp.2025.117556_b0245","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.bcp.2025.117556_b0250","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41556-023-01185-x","article-title":"STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2","volume":"25","author":"Zhang","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117556_b0255","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/ATVBAHA.124.320665","article-title":"Glycolytic PFKFB3 and glycogenic UGP2 axis regulates perfusion recovery in experimental hind limb ischemia","volume":"44","author":"Jaiyesimi","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117556_b0260","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1016\/j.ygeno.2020.06.044","article-title":"A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors","volume":"112","author":"Cui","year":"2020","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s43018-021-00279-5","article-title":"Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis","volume":"3","author":"Shen","year":"2022","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0270","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13046-022-02404-3","article-title":"Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0275","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41419-025-07923-3","article-title":"NLRP12 decreases TRIM25-mediated HK2 degradation to promote glycolysis and H3K18la in gastric cancer","volume":"16","author":"Zhou","year":"2025","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bcp.2025.117556_b0280","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3892\/ol.2025.15339","article-title":"Advancements in research on the role of the key glycolytic enzyme hexokinase 2 in the regulation of tumor immune evasion (Review)","volume":"30","author":"Qian","year":"2025","journal-title":"Oncol. Lett."},{"issue":"13","key":"10.1016\/j.bcp.2025.117556_b0285","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1002\/cam4.2463","article-title":"Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer","volume":"8","author":"Fan","year":"2019","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117556_b0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41419-025-07399-1","article-title":"CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance","volume":"16","author":"Zheng","year":"2025","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2025.117556_b0295","first-page":"861","article-title":"Glycolysis in the progression of pancreatic cancer","volume":"12","author":"Chang","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117556_b0300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41417-024-00864-7","article-title":"ITGA3 promotes pancreatic cancer progression through HIF1\u03b1- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner","volume":"32","author":"Li","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"34","key":"10.1016\/j.bcp.2025.117556_b0305","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/s41388-025-03483-0","article-title":"ZMYND8 promotes the Warburg effect and tumorigenesis through c-Myc activation in pancreatic cancer","volume":"44","author":"Liu","year":"2025","journal-title":"Oncogene"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:22:51Z","timestamp":1781065371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"alternative-id":["S0006295225008214"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117556","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MMP28 promotes tumorigenesis and gemcitabine resistance in pancreatic cancer by promoting glycolysis through interaction with SND1","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117556"}}